Free cash flow
Bristol-Myers Squibb Free cash flow decreased by 52.8% to $757.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 55.3%, from $1.69B to $757.00M. Over 4 years (FY 2021 to FY 2025), Free cash flow shows a downward trend with a -4.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase suggests strong operational efficiency and the ability to self-fund future innovation or return capital to shareholders, while a decrease may indicate heavy capital expenditure cycles or declining operational profitability.
Detailed definition
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and m...
Peer comparison
High-growth semiconductor and AI infrastructure peers typically prioritize reinvestment, so free cash flow margins are often compared against R&D intensity and capital expenditure requirements of industry rivals.
cf_free_cash_flowHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.85B | $5.00B | $3.74B | $3.56B | $1.99B | $3.44B | $2.96B | $2.69B | $1.63B | $4.41B | $3.92B | $2.55B | $2.06B | $5.27B | $4.06B | $1.69B | $3.56B | $5.99B | $1.60B | $757.00M |
| QoQ Change | — | +75.3% | -25.2% | -4.8% | -44.1% | +73.0% | -14.0% | -9.1% | -39.5% | +170.8% | -11.0% | -35.0% | -19.1% | +155.2% | -22.9% | -58.3% | +109.9% | +68.5% | -73.2% | -52.8% |
| YoY Change | — | — | — | — | -30.2% | -31.1% | -20.8% | -24.4% | -18.1% | +28.2% | +32.5% | -5.3% | +26.8% | +19.5% | +3.5% | -33.6% | +72.3% | +13.7% | -60.5% | -55.3% |
Free cash flow at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's free cash flow?
- Bristol-Myers Squibb (BMY) reported free cash flow of $757.00M in Q1 2026.
- How has Bristol-Myers Squibb's free cash flow changed year-over-year?
- Bristol-Myers Squibb's free cash flow decreased by 55.3% year-over-year, from $1.69B to $757.00M.
- What is the long-term trend for Bristol-Myers Squibb's free cash flow?
- Over 4 years (2021 to 2025), Bristol-Myers Squibb's free cash flow has grown at a -4.2% compound annual growth rate (CAGR), from $15.23B to $12.85B.
- What does free cash flow mean?
- The cash a company has left over after paying for its operating expenses and capital investments.